Skip to content

PEMOCS: Personalized Motor-cognitive Training in Chronic Stroke

PEMOCS: Effects of a Concept-guided, PErsonalized, MOtor-Cognitive Training in Chronic Stroke - a RCT

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05524727
Enrollment
38
Registered
2022-09-01
Start date
2022-09-01
Completion date
2024-07-31
Last updated
2024-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

cognition, gait, mobility, training, chronic stroke, rehabilitation, virtual reality

Brief summary

In Switzerland, approximately 20'000 persons suffer a stroke each year. Despite carefully considered rehabilitation programs, full recovery is achieved only in a small proportion of stroke survivors (www.swissheart.ch). Studies suggest that motor-cognitive trainings can improve gait, balance, and mobility in chronic stoke survivors. However, little is known about the effect of motor-cognitive trainings on cognitive functioning in chronic stroke. The aim of this study is to evaluate the effects of a motor-cognitive training added to usual care compared to usual care alone on cognitive functions, single- and dual-task mobility, gait and health-related quality of life. In this single-blind RCT, 38 participants will be allocated randomly to either the intervention group (usual care + motor-cognitive training by means of an exergame for 12 weeks, 2x/week for 30-40 minutes) or the control group (usual care only). Both groups will attend three assessments, at baseline, post-intervention (12 weeks after baseline), and at follow-up (24 weeks after baseline). Global cognitive functioning will be the primary endpoint and a linear mixed model will be used for analysis. Motor-cognitive trainings, especially exergames, bear the potential for further development of innovative long-term rehabilitation solutions for chronic stroke survivors. Cognitive deficits are a common unmet need restricting daily activities mentioned by chronic stroke survivors. Exergame training following personally tailored progression to generate optimal training load may help addressing this unmet need. Therefore, this study will contribute to the on-going research objective on how to improve the long-term care of stroke patients.

Interventions

OTHERConcept-guided, personalized, motor-cognitive training by means of an exergame

12 weeks, two times per week for 30-40min

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

RCT

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults (\> 18 years) with chronic stroke (≥ 6 months post-stroke) * Stroke: ischemic or haemorrhagic * Able to stand for 3 minutes and walk 10 meters, functional ambulation category ≥ 3 * Able to follow a two-stage command * Able to give informed consent as documented by signature

Exclusion criteria

* Unable or not willing to give informed consent * Other neurological diseases (e.g. Parkinson's Disease, multiple sclerosis), except cognitive deficits or dementia * Clinical contra-indications for the study intervention * Unable to follow the study intervention or the test for the primary endpoint (MoCA), e.g. due to a neglect, aphasia or other language problems * Overlapping enrolment in another clinical trial

Design outcomes

Primary

MeasureTime frameDescription
Change of Montreal Cognitive Assessment Scoreweek 0, week 12 and week 24Widely used screening tool and cognitive outcome in neurological patients including stroke

Secondary

MeasureTime frameDescription
Change of Outdoor Gait Parametersweek 0, week 12 and week 24Assesses walking endurance and spatiotemporal gait parameters under daily-life conditions.
Change of Trail Making Test A & B Parametersweek 0, week 12 and week 24Widely used reliable and valid neuropsychological test assessing processing speed and executive functions
Change of Stroop Interference Test Parametersweek 0, week 12 and week 24Widely used reliable and valid neuropsychological test assessing the ability to inhibit the reaction to a more dominant stimulus in favour of the inquired reaction to a less dominant stimulus
Change of N-back test Parametersweek 0, week 12 and week 24Widely used reliable and valid neuropsychological test assessing working memory and related cognitive functions
Change of Mental Rotation Test Parametersweek 0, week 12 and week 24Measures the ability to mentally rotate abstract objects
Change in Single- and cognitive Dual-Task Timed Up and Go Test Parameters and motor/cognitive dual task costsweek 0, week 12 and week 24Widely used, reliable and valid test of mobility and dual-task ability in various populations including stroke.
Change of 10 meter walk test Gait Parametersweek 0, week 12 and week 24Widely used test to assess gait speed and spatiotemporal gait parameters.
Change of Stroke Impact Scale 3.0 Scoreweek 0, week 12 and week 24Stroke-specific measurement tool assessing patient-reported health-related quality of life
Change of Simple Reaction Test Parametersweek 0, week 12 and week 24Widely used reliable and valid neuropsychological test assessing alertness

Other

MeasureTime frameDescription
Adherence Rateweek 12attended training time / offered training time
Perceived Motor-Cognitive Task Difficultytwice per week, week 0-12visual analogue scale after each training session, based on cognitive load theory, scale from 1-9, where 9 symbolizes most difficult
Perceived Performancetwice per week, week 0-12visual analogue scale after each training session, performance item of the National Aeronautics and Space Administration - Task Load Index, scale from 0 to 20, where 20 symbolizes highest performance
Dose and Content of Usual Careonce per week, week 0-24according to weekly questionnaire, based on TIDIeR checklist
Amount and Intensity of General Physical and Cognitive Activityonce per week, week 0-24according to weekly questionnaire, based on TIDIeR checklist
Compliance Rateweek 12attended sessions / offered sessions

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026